首页> 外文OA文献 >Synthesis and in vitro cytostatic activity of new beta-D-arabino furan1',2':4,5oxazolo- and arabino-pyrimidinone derivatives
【2h】

Synthesis and in vitro cytostatic activity of new beta-D-arabino furan1',2':4,5oxazolo- and arabino-pyrimidinone derivatives

机译:新型β-D-阿拉伯糖呋喃1',2':4,5恶唑啉-和阿拉伯嘧啶酮衍生物的合成及体外抑细胞活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of nucleoside derivatives was obtained via heteroatom annulation of the amino oxazoline of D-(-)-arabinose. Unequivocal proofs for the stereostructure of some new arabinosyl pyrimidinone derivatives were obtained by X-ray structure analysis. These newly synthesized compounds were then evaluated for their cytostatic activity against murine leukemia (L1210), and human T-lymphocytes (Molt 4/C8 and CEM). Of all the compounds in the series, the protected silylated tricyclic fused pyrimidinone 10 showed the most significant antitumor activity against murine leukemia L1210 (IC(50)=6 microM), and human T-lymphocytes cells Molt 4/C8 (IC(50)=7.9 microM) and CEM/0 cell lines (IC(50)=7.5 microM). None of the compounds exhibited significant antiviral inhibitory activities.
机译:通过D-(-)-阿拉伯糖的氨基恶唑啉的杂原子环化获得了一系列核苷衍生物。通过X射线结构分析获得了一些新的阿拉伯糖基嘧啶酮衍生物的立体结构的明确证据。然后评估这些新合成的化合物对鼠白血病(L1210)和人T淋巴细胞(Molt 4 / C8和CEM)的抑制细胞活性。在该系列的所有化合物中,受保护的甲硅烷基化的三环稠合嘧啶酮10对鼠白血病L1210(IC(50)= 6 microM)和人类T淋巴细胞Molt 4 / C8(IC(50))显示出最显着的抗肿瘤活性。 = 7.9 microM)和CEM / 0细胞系(IC(50)= 7.5 microM)。这些化合物均未显示出显着的抗病毒抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号